Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IKF (Institut für Klinische Forschung) is a specialized clinical research organization and site management organization based in Frankfurt, Germany, with a primary focus on oncology and hematology. The institute is recognized for its leadership in conducting academic and industry-sponsored clinical trials, particularly in gastrointestinal cancers. Founded and led by Prof. Dr. med. Salah-Eddin Al-Batran, IKF provides a full suite of services including trial design, regulatory management, and clinical monitoring. It operates as a hub for multicenter international studies, bridging the gap between innovative pharmaceutical development and clinical practice. The organization is well-known for managing the influential FLOT trials which have set new standards of care in gastric cancer treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IKF.